Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
AIDS Malignancy Consortium
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)